1982
DOI: 10.1128/iai.35.2.442-448.1982
|View full text |Cite
|
Sign up to set email alerts
|

Complement consumption gonococcal peptidoglycan

Abstract: Purified peptidoglycan (PG) obtained from Neisseria gonorrhoeae was tested for the ability to consume complement in normal human sera. Sonicated PG (S-PG), a heterogeneous mixture of soluble fragments (molecular weight, greater than 10(6)), as well as intact (insoluble) PG, reduced the level of whole hemolytic complement in a pool of four human sera. The minimal concentration of S-PG required for this activity was approximately 500 micrograms of S-PG per ml of serum. Complete lysozyme digestion of S-PG, yieldi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
10
0

Year Published

1985
1985
1994
1994

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 20 publications
(11 citation statements)
references
References 23 publications
(24 reference statements)
1
10
0
Order By: Relevance
“…To test this hypothesis, our main objectives have been to identify and purify those PG fragments that might arise in vivo and to test their biological activities in diverse assays that are associated with modulation of inflammation and immunity. In general, we have found that various classes of physiologically realistic PG fragments possess numerous activities consistent with the notion that PG plays a role in gonococcal disease, e.g., toxicity (14), ability to activate complement (15), arthritogenicity (6), and ability to stimulate the release of functional interleukin-1 and prostaglandin E2 (T. J. Fleming and S. L. Myers, Abstr. Annu.…”
supporting
confidence: 76%
See 1 more Smart Citation
“…To test this hypothesis, our main objectives have been to identify and purify those PG fragments that might arise in vivo and to test their biological activities in diverse assays that are associated with modulation of inflammation and immunity. In general, we have found that various classes of physiologically realistic PG fragments possess numerous activities consistent with the notion that PG plays a role in gonococcal disease, e.g., toxicity (14), ability to activate complement (15), arthritogenicity (6), and ability to stimulate the release of functional interleukin-1 and prostaglandin E2 (T. J. Fleming and S. L. Myers, Abstr. Annu.…”
supporting
confidence: 76%
“…However, a recurrent theme to date is that several activities are potentiated by the persistence of highmolecular-weight PG. This persistence correlates closely with PG hydrolase resistance afforded by extensive substitution of glycan chains with O-acetyl residues (2,6,15,(19)(20)(21). Thus, for exatnple, extensively 0-acetylated PG (O-PG) exhibits greater resistance to commercial and human lysozyme (muramidase) and is more highly arthropathic than * Corresponding author.…”
mentioning
confidence: 92%
“…In regard to the second objective, the essential conclusion is that purified PG fragments collectively do initiate biological reactions compatible with their playing a role in modulation of the host reaction to gonococcal infection. Gonococcal PG-mediated activities include (i) intrinsic toxicity for human fallopian tube mucosa (21), (ii) consumption of human complement and generation of active mediators of inflammation (24) Biemann, manuscript in preparation) have indicated that anihydro-muramic acid-containing monomers, released by growing gonococci, induce slow-wave sleep in experimental animals. This conclusion is consistent with the original observations on the somnogenic properties of muramyl peptides (18) in that a major component of anhydromonomers (the disaccharide tetrapeptide) is identical to the naturally occurring somnogenic factor (factor S) present in numerous animals including humans (17,20,32).…”
mentioning
confidence: 99%
“…(i) Sonicated (S) PG, e.g., S-O-PG and S-non-O-PG, prepared from O-PG and non-O-PG as described previously(24), were heterogeneous mixtures of soluble fragments (greater than 106 daltons) that simulated the large-molecular-weight fragments released by the action of host PG hydrolases (27), e.g., human polymorphonuclear leukocyte lysozyme. S-PG preparations used in experiments contained between less than 0.1 to 0.9% (wt/wt) non-PG amino acids, and between 0.05 and 0.25 ng of lipopolysaccharide (LPS) per ,ug of PG, as determined by the Limulus amoebocyte lysate assay (see below).…”
mentioning
confidence: 99%
“…Another aspect of gonococcal biology in which the diverse peptidoglycan structures may be of importance is host interactions. Gonococci exhibit substantial cell wall turnover, and release of gonococcal peptidoglycan fragments has been implicated in several pathological host responses (10,13). The possibility of variations in host effects by different peptidoglycan subunits must be entertained.…”
Section: Discussionmentioning
confidence: 99%